Abstract 10314: Post-GWAS Functional Genomics Analysis of CBLN2 Locus to Define the Pathogenic Role of CUX1 in Pulmonary Arterial Hypertension

Wei Sun,Danli Jiang,Ting Wu,Meijuan Zou,Gang Li,Stephen Y Chan
DOI: https://doi.org/10.1161/circ.144.suppl_1.10314
IF: 37.8
2021-11-16
Circulation
Abstract:Introduction: Pulmonary arterial hypertension (PAH) is a rare but morbid disease and highly relevant to genetic susceptibility. Genome-wide Association Studies (GWAS) have identified 12 SNPs on 9 PAH- associated loci. However, GWAS is unable to identify the causative functional SNPs (fSNP) or define the mechanisms by which a fSNP regulates the risk gene expression. Methods: We developed a novel functional genomics analysis to identify PAH-associated fSNPs. It includes Reel-seq (Regulatory element-sequencing), an EMSA-based high-throughput technique, to identify fSNPs in a synthetic DNA library containing PAH-associated SNPs; SDCP-MS (SNP-specific DNA competition pulldown-mass spectrometry) to identify proteins that specifically bind to fSNPs; and AIDP-Wb (allele-imbalanced DNA pulldown-Western blot) to show allele-imbalanced binding of these proteins to fSNPs. The regulation of risk gene expression by these fSNP-binding proteins was determined in PAECs and confirmed in PAH patients. Results: By Reel-seq, rs11151770 is identified a fSNP in the CBLN2 locus, and its risk allele A is associated with a 1.97-fold increase in PAH susceptibility. By using SDCP-MS and AIDP-Wb, transcription factor CUX1 was found to specifically bind to this fSNP, with higher affinity to the risk allele A than non-risk allele G, thus controlling the expression of CBLN2. CUX1 knockdown prevented, but CUX1 overexpression induced, the pathophenotypes in PAECs that are associated with PAH. CUX1-CBLN2 was upregulated by the acquired PAH trigger IL-1β, and was also increased in PAH lungs. Genotyping of this fSNP showed a 2.1-fold risk allele A enrichment in PAH patients associated with connective tissue disorders, supporting a pathogenic mechanism of an inflammation-sensitive pathway (CUX1-CBLN2) combined with a PAH susceptible genotype (risk allele A) for the manifestation of clinical PAH. Conclusion: We demonstrate that CUX1 regulates the expression of target gene CBLN2 via binding to fSNP rs11151770. Alteration of CBLN2 expression, in turn, controls crucial endothelial function relevant to PAH. These results identify a novel role of CUX1 in PAH, clarifying the pathogenic function of this PAH-associated locus and providing a potential target for PAH intervention.
cardiac & cardiovascular systems,peripheral vascular disease
What problem does this paper attempt to address?